SCHEMBL417823

SCHEMBL417823

CCCOc1ccc(/C=C/C(=O)O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.65
THRB P10828 1/20 0.62
ATM Q13315 1/20 0.62
KDM4E B2RXH2 3/20 0.61
POLB P06746 1/20 0.60
NPC1 O15118 4/20 0.59
RAB9A P51151 4/20 0.59
CYP1A1 P04798 1/20 0.59
CYP1B1 Q16678 1/20 0.59
TBXAS1 P24557 2/20 0.56
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
PTGS1 P23219 1/20 0.55
PTGS2 P35354 1/20 0.55
LMNA P02545 2/20 0.54
NPSR1 Q6W5P4 1/20 0.54
ALDH1A1 P00352 2/20 0.54
HTT P42858 1/20 0.54
MAPT P10636 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL417824 1.00 ABCG2 (0.65) ABCG2THRBATMKDM4EPOLB
Hydrochloric Acid SCHEMBL7054655 0.98 ABCG2 (0.63) ABCG2THRBATMKDM4EPOLB
SCHEMBL8999226 0.95 ABCG2 (0.60) ABCG2THRBATMKDM4EPOLB
SCHEMBL154581 0.93 ABCG2 (0.65) ABCG2THRBATMPOLBTBXAS1
SCHEMBL1206856 0.93 ABCG2 (0.65) ABCG2THRBATMPOLBTBXAS1
SCHEMBL23419144 0.91 POLB (0.59) ABCG2THRBATMKDM4EPOLB
SCHEMBL1942953 0.90 ABCG2 (0.62) ABCG2THRBATMPOLB
SCHEMBL1551186 0.90 ABCG2 (0.62) ABCG2THRBATMPOLB
SCHEMBL11686354 0.90 THRB (0.65) THRBATMPOLBTBXAS1KMT2A
SCHEMBL15164000 0.90 ABCG2 (0.54) ABCG2THRBATMKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122095297-A Composition for forming cured film, alignment material, and phase difference material 2026-05-26 CN disclosed
WO-2025088969-A1 COMPOSITION FOR FORMING CURED FILM, CURED FILM, ALIGNMENT MATERIAL, AND RETARDATION MATERIAL 日産化学株式会社 2025-05-01 WO disclosed
WO-2025023309-A1 COMPOSITION FOR FORMING CURED FILM, ALIGNMENT MATERIAL, AND PHASE-DIFFERENCE MATERIAL 日産化学株式会社 2025-01-30 WO disclosed
CN-119053661-A Composition for forming cured film, alignment material, and retardation material 日产化学株式会社 2024-11-29 CN disclosed
CN-119053888-A Resin composition for thermosetting photo-alignment film 日产化学株式会社 2024-11-29 CN disclosed
CN-118715462-A Resin composition for thermosetting photo-alignment film 日产化学株式会社 2024-09-27 CN disclosed
WO-2023204281-A1 RESIN COMPOSITION FOR THERMOSETTING PHOTO-ALIGNMENT FILMS 日産化学株式会社 2023-10-26 WO disclosed
WO-2023204280-A1 CURED FILM-FORMING COMPOSITION, ALIGNMENT MATERIAL, AND RETARDATION MATERIAL 日産化学株式会社 2023-10-26 WO disclosed
WO-2023157934-A1 RESIN COMPOSITION FOR THERMOSETTING PHOTO-ALIGNMENT FILMS 日産化学株式会社 2023-08-24 WO disclosed
US-20230139366-A1 BRARTEMICIN ANALOGUES VICTORIA LINK LIMITED (NZ) 2023-05-04 US disclosed
EP-0590919-A1 Therapeutic agents for parkinson's disease KYOWA HAKKO KOGYO CO., LTD. (JP) 1994-04-06 EP disclosed
EP-0565377-A1 Therapeutic agents for use in the treatment of parkinson's disease KYOWA HAKKO KOGYO CO., LTD. (JP) 1993-10-13 EP disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed
US-5139696-A Hydrogen-bonded liquid crystal complexes CORNELL RESEARCH FOUNDATION, INC. (US) 1992-08-18 US disclosed
US-5037574-A Hydrogen-bonded liquid crystal complexes CORNELL RESEARCH FOUNDATION, INC. (US) 1991-08-06 US disclosed
EP-0395446-A2 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists Sankyo Company Limited (JP) 1990-10-31 EP disclosed
US-RE32944-E Aromatic carboxylic amide derivatives Kissei Yakuhin Kogyo Kabushiki (JP) 1989-06-06 US disclosed
US-4070484-A Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same KISSEI PHARMACEUTICAL CO., LTD. (JA) 1978-01-24 US disclosed
US-4026896-A ANTIALLERGENS KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (KISSEI PHARMACEUTICAL CO. LTD.) (JA) 1977-05-31 US disclosed
US-3940422-A ANTIALLERGEN KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (JA) 1976-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230139366-A1 BRARTEMICIN ANALOGUES RXFP1, RXFP2, RXFP4 ABCG2 4866/4885THRB 1320/4885ATM 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.